• O NAMA

Welcome

Forgot password?

Not a member? Join today

Logo
  • Početna
  • Bolesti
    • Hronična limfocitna leukemija
    • Non hočkinski limfom
    • Hočkinski limfom
    • Leukemije
      • AML
      • ALL
  • Edukacija
    • Prezentacije
      • HLL
      • NHL
      • HL
    • Kvizovi
      • HLL
      • NHL
      • HL
  • Stil života
    • Zdraviji recepti
    • Fizička aktivnost
    • Prevencija
    • Korisni saveti
  • Resursi
    • Video
    • Brošure
    • Infografike
  • Blog
  • English
  • Početna
  • Bolesti
    • Hronična limfocitna leukemija
    • Non hočkinski limfom
    • Hočkinski limfom
    • Leukemije
      • AML
      • ALL
  • Edukacija
    • Prezentacije
      • HLL
      • NHL
      • HL
    • Kvizovi
      • HLL
      • NHL
      • HL
  • Stil života
    • Zdraviji recepti
    • Fizička aktivnost
    • Prevencija
    • Korisni saveti
  • Resursi
    • Video
    • Brošure
    • Infografike
  • Blog
  • English
22 Oct 2018
  • maja
  • Uncategorized

Evaluating the risk of developing acute myeloid leukemia or myelodysplastic syndrome after a stem cell transplant

Evaluating the risk of developing acute myeloid leukemia or myelodysplastic syndrome after a stem cell transplant This study evaluated the risk

Read More

22 Oct 2018
  • maja
  • Uncategorized

Hodgkin Lymphoma Above and Below the Diaphragm: Are The Outcomes Different?

Hodgkin Lymphoma Above and Below the Diaphragm: Are The Outcomes Different? This study investigated the development of Hodgkin lymphoma (HL)

Read More

22 Oct 2018
  • maja
  • Hronična limfocitna leukemija

Chlorambucil, rituximab and lenalidomide combination treatment for patients with chronic lymphocytic leukemia

Chlorambucil, rituximab and lenalidomide combination treatment for patients with chronic lymphocytic leukemia This study aimed to evaluate the

Read More

22 Oct 2018
  • maja
  • Hronična limfocitna leukemija

Evaluating the safety of ibrutinib in leukemia and lymphoma

Evaluating the safety of ibrutinib in leukemia and lymphoma This study looked at the evidence for the safety of ibrutinib (Imbruvica) in the

Read More

13 Apr 2018
  • maja
  • Nehočkinski limfom

Diffuse large B-cell lymphoma: 10 years’ real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone

Diffuse large B-cell lymphoma: 10 years’ real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and

Read More

  • 1
  • 2
  • 3
  • …
  • 5

Pretraga

Najnoviji postovi

  • Evaluating the risk of developing acute myeloid leukemia or myelodysplastic syndrome after a stem cell transplant
  • Hodgkin Lymphoma Above and Below the Diaphragm: Are The Outcomes Different?
  • Chlorambucil, rituximab and lenalidomide combination treatment for patients with chronic lymphocytic leukemia
  • Evaluating the safety of ibrutinib in leukemia and lymphoma
  • Diffuse large B-cell lymphoma: 10 years’ real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone

Arhiva

  • October 2018
  • April 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017

Kalendar

June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Oct    

Categories

  • Hočkinov limfom (3)
  • Hronična limfocitna leukemija (9)
  • Nehočkinski limfom (4)
  • Uncategorized (8)

Novosti

Follow Us

Izradu platforme podržala kompanija

KONTAKT

Udruženje LIPA
+ 381 60 0 222 317
majaklipa@gmail.com
www.lipa.org.rs

Budite u toku sa najnovijim dešavanjima. Prijavite se

© Copyright LIPA 2017